RecruitingNot ApplicableNCT07360587

Thyroid Artery Embolization for the Treatment of Compressive Goiters.

Thyroid Artery Embolization for the Treatment of Compressive Goiters: a Prospective Cohort Study.


Sponsor

Université de Sherbrooke

Enrollment

20 participants

Start Date

Jan 31, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Very few studies have investigated TAE as a treatment for goiter with compressive symptoms. What is the efficacy and safety of TAE for the treatment of compressive goiters in a population ineligible for or refusing standard therapy? This is a prospective interventional cohort study that will allow us to standardize imaging by improving quality data collection and fellow-up to assess the efficacy of TAE for compressive symptoms of nodular goiters. Not only to corroborate current emerging results but clearly define the expected results for this technique.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests a procedure called thyroid artery embolization (TAE) — which blocks blood flow to an enlarged thyroid gland — as a way to shrink large goiters (enlarged thyroid) that are pressing on the throat or airway in people who cannot or do not want surgery. **You may be eligible if...** - You have a goiter (enlarged thyroid) causing compression of your throat, windpipe, or esophagus, or causing significant symptoms - You are not a candidate for surgery or other ablative treatments, OR you prefer this procedure over those options - Your thyroid nodules are rated low-to-intermediate risk on ultrasound (TI-RADS 1–4) - Your thyroid biopsy results are benign or indeterminate (Bethesda I, II, or III) - You are at least 18 years old **You may NOT be eligible if...** - You have a nodule classified as highly suspicious for cancer (TI-RADS 5 or Bethesda IV–VI) - You have uncontrolled severe hyperthyroidism - You have medical conditions that prevent you from having an endovascular (catheter-based) procedure - You are a minor (under 18) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREThyroid Artery Embolization

Interruption of blood flow that supplies thyroid nodule using embolization technique.


Locations(1)

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07360587


Related Trials